Genscript Biotech Corp

01548

Company Profile

  • Business description

    GenScript Biotech Corp is an investment holding company engaged in the manufacture and sale of life science research products and services, including life science services and products, biologics development services, and industrial synthetic biology products. Its segments include life science services and products, which generate maximum revenue and provide research services and products; biologics development services, which support the development of therapeutic antibodies and CGT products; industrial synthetic biology, which provides enzyme development and production using engineered microbial strains; and the operation unit, which provides shared services. It operates in Mainland China, which generates maximum revenue, U.S., Europe, and the Asia Pacific excluding Mainland China.

  • Contact

    860 Centennial Avenue
    PiscatawayNJ08854
    USA

    https://www.genscript.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Biotechnology

    Fiscal Year End

    31 December 2026

    Employees

    6,165

Stocks News & Analysis

stocks

Cheap ASX share may have more room to run

Shares are cheap despite rebounding share price, yet risks remain.
stocks

ASX listed media giant drives strong earnings growth

Digital growth drives earnings beat for media share.
stocks

ASX real estate platform outperforms yet questions remain

Valuation remains a key concern despite strong August reporting.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries9,424.3013.10-0.14%
CAC 408,714.9315.220.17%
DAX 4026,319.45179.320.69%
Dow JONES (US)54,036.93151.830.28%
FTSE 10010,901.0933.200.31%
HKSE25,880.11212.080.83%
NASDAQ26,690.62342.261.30%
Nikkei 22566,879.121,272.411.94%
NZX 50 Index13,888.2464.110.46%
S&P 5007,757.6447.680.62%
S&P/ASX 2009,233.4016.20-0.18%
SSE Composite Index3,952.5412.500.32%

Market Movers